A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands

被引：0
|
作者：
Gericke, Germo [1 ]
机构：
[1] Novartis Co, Adv Accelerator Applicat, CH-1204 Geneva, Switzerland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / 09期
关键词：
1;
D O I：
10.1007/s00259-021-05400-5
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：2666 / 2667
页数：2
相关论文
共 50 条
  • [41] Concomitant Dosimetry during 177-Lu labelled Radionuclide therapy in comparison with conventional Dosimetry using 111-In labelled peptides
    Heute, D.
    Dobrozemsky, G.
    Warwitz, B.
    Gabriel, M.
    von Guggenberg, E.
    Virgolini, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S375 - S375
  • [42] South African guidelines for receptor radioligand therapy (RLT) with Lu-177-PSMA in prostate cancer
    Vorster, M.
    Warwick, J.
    Lawal, I. O.
    du Toit, P.
    Vangu, M.
    Nyakale, N. E.
    Steyn, R.
    Gutta, A. A.
    Hart, G.
    Mutambirwa, S.
    Ellmann, A.
    Sathekge, M. M.
    SOUTH AFRICAN JOURNAL OF SURGERY, 2019, 57 (04) : 45 - 51
  • [43] Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)
    Mei-Chun Yeh
    Brian W. C. Tse
    Nicholas L. Fletcher
    Zachary H. Houston
    Maria Lund
    Marianna Volpert
    Chelsea Stewart
    Kamil A. Sokolowski
    Varinder Jeet
    Kristofer J. Thurecht
    Douglas H. Campbell
    Bradley J. Walsh
    Colleen C. Nelson
    Pamela J. Russell
    EJNMMI Research, 10
  • [44] Dose-dependent relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radionuclide therapy
    Rumiantcev, M.
    Li, W.
    Lindner, S.
    Liubchenko, G.
    Resch, S.
    Bartenstein, P.
    Ziegler, S.
    Boening, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S363 - S363
  • [45] Correction to: Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure (vol 58, pg 381, 2024)
    Abdlkadir, Ahmed Saad
    Abufara, Alaa
    Al-Ibraheem, Akram
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 59 (01) : 94 - 94
  • [46] Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)
    Yeh, Mei-Chun
    Tse, Brian W. C.
    Fletcher, Nicholas L.
    Houston, Zachary H.
    Lund, Maria
    Volpert, Marianna
    Stewart, Chelsea
    Sokolowski, Kamil A.
    Jeet, Varinder
    Thurecht, Kristofer J.
    Campbell, Douglas H.
    Walsh, Bradley J.
    Nelson, Colleen C.
    Russell, Pamela J.
    EJNMMI RESEARCH, 2020, 10 (01)
  • [47] PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
    Kratochwil, Clemens
    Giesel, Frederik L.
    Stefanova, Melsa
    Benesova, Martina
    Bronzel, Marcus
    Afshar-Oromieh, Ali
    Mier, Walter
    Eder, Matthias
    Kopka, Klaus
    Haberkorn, Uwe
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (08) : 1170 - 1176
  • [48] [177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer
    Rahbar, Kambiz
    Ahmadzadehfar, Hojjat
    Seifert, Robert
    Boegemann, Martin
    LANCET ONCOLOGY, 2018, 19 (08): : E371 - E371
  • [49] EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2
    Darcourt, Jacques
    Booij, Jan
    Tatsch, Klaus
    Varrone, Andrea
    Borght, Thierry Vander
    Kapucu, Oezlem L.
    Nagren, Kjell
    Nobili, Flavio
    Walker, Zuzana
    Van Laere, Koen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (02) : 443 - 450
  • [50] EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2
    Jacques Darcourt
    Jan Booij
    Klaus Tatsch
    Andrea Varrone
    Thierry Vander Borght
    Özlem L. Kapucu
    Kjell Någren
    Flavio Nobili
    Zuzana Walker
    Koen Van Laere
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 443 - 450
12345